The Future of Value-Based Care During the Trump Administration

News
Video

Luke Hansen, M.D., M.H.S., and chief medical officer of Arcadia, a healthcare data analytics company, said that achieving value-based care will need to be a multipronged approach with commercial purchasers and state Medicaid programs playing a prominent role.

The future of value-based care under the current Trump administration depends on a variety of factors, according to Luke Hansen, M.D., M.H.S., and chief medical officer of Arcadia.

Luke Hansen, M.D., M.H.S.

Luke Hansen, M.D., M.H.S.

“Changes in administration are an opportunity to reexamine the success of previous programs,” Hansen said in a video interview with Managed Healthcare Executive. “My take on it is that it's going to take a recipe, it's going to take a mix, because you need incentives for PCPs, but you also need additional incentives for specialists that haven't existed yet, and you need incentives for other kinds of key stakeholders in the industry.”

He explained his point further by using a multihospital health system as an example.

“So, a multihospital health system, have they really been incentivized to chase total cost of care? And how can we build a program that will do that?” “Because the Medical Shared Savings Programs and the other Accountable Care Organizations iterations since then, there are savings that absolutely accrue to Medicare, but when those savings are taken out of the revenue stream of the sponsor organization, there's a tension there that I wish we could get past. How can we set up a system where all the stakeholders benefit through more efficient care?”

Hansen also mentioned the important role states play in the Medicaid program.

If [states’] overall revenue availability for Medicaid starts to shrink, the states are going to have to be creative, and that might be a driver of value-based care,” Hansen said. “Hopefully the states can be stewards in the Medicaid program with flexibilities that they didn't have before.

Recent Videos
2 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.